Clinical Trials of Antifungal Therapies

Dismukes, William E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research and Development Contracts (N01)
• Project #: N01AI065296-001
• Application #: 2296616
• Project Start: 1995-10-21
• Project End: 2000-10-20
• Budget Start: 1996-06-12
• Budget End: 1996-10-20
• Fiscal Year: 1996

Institution

• Name: University of Alabama Birmingham
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 004514360
• City: Birmingham
• State: AL
• Country: United States
• Zip Code: 35294

Publications

Hadley, S; Huckabee, C; Pappas, P G et al. (2009) Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis 11:40-8

Dismukes, William E (2006) Antifungal therapy: lessons learned over the past 27 years. Clin Infect Dis 42:1289-96

Wheat, L Joseph; Connolly, Patricia; Smedema, Melinda et al. (2006) Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 57:1235-9

Larsen, Robert A; Pappas, Peter G; Perfect, John et al. (2005) Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother 49:952-8

van Burik, Jo-Anne H; Ratanatharathorn, Voravit; Stepan, Daniel E et al. (2004) Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 39:1407-16

Wheat, L Joseph; Kauffman, Carol A (2003) Histoplasmosis. Infect Dis Clin North Am 17:1-19, vii

Wheat, L Joseph; Connolly, Patricia; Haddad, Nicholas et al. (2002) Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. Antimicrob Agents Chemother 46:248-50

Walsh, Thomas J; Pappas, Peter; Winston, Drew J et al. (2002) Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346:225-34

Wheat, L J; Connolly, P; Smedema, M et al. (2001) Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis 33:1910-3

Hajjeh, R A; Pappas, P G; Henderson, H et al. (2001) Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 32:1215-20